A high-throughput study in melanoma identified EMT as a major determinant of metastasis; these results were confirmed in melanoma samples using tissue microarray, where a set of proteins included in the EMT group (N-cadherin, osteopontin, and SPARC/osteonectin) was significantly associated with metastasis development. This evidence concerns the gene SPARC and melanoma.